Fc receptor-like 3 - 169 C/T polymorphism and RA susceptibility

A meta-analysis

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The Fc receptor-like 3 (FCRL3) -169 C/T polymorphism has been reported to be associated with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), but with inconsistent results. The aim of this study was to explore whether the FCRL3 -169 C/T polymorphism confers susceptibility to RA and SLE. The authors conducted a random effect meta-analysis on the associations between the C/C (recessive effect) or C/C + C/T (dominant effect) genotype or the allele C of the FCRL3 -169 polymorphisms and RA or SLE in different populations. In total, 15 separate comparisons, 12 for RA and 3 for SLE, drawn from nine European and six Asian population samples were included in this meta-analysis. No association between RA and the FCRL3 C allele was found for all study subjects (OR = 1.064, 95% CI = 0.987-1.146, p = 0.107). However, stratification by ethnicity indicated that the FCRL3 C allele was significantly associated with RA in Asians (OR = 1.203, 95% CI = 1.097-31.319, p < 0.001). Conversely, no association was detected for this allele and RA in Europeans (OR = 0.997, 95% CI = 0.931- 1.068, p = 0.933). The ORs for the C/C + C/T and C/C genotypes in these ethnic groups showed the same trends as the FCRL3 C allele. An association between SLE and the FCRL3 -169 A allele was found in all study subjects (OR = 1.115, 95% CI = 1.003-1.240, p = 0.043), but metaanalysis excluding studies with controls not in HWE did not show the association. This meta-analysis suggests that the FCRL3 -169 C/T polymorphism is a significant risk factor for RA in Asians, but not in Europeans.

Original languageEnglish
Pages (from-to)947-953
Number of pages7
JournalRheumatology International
Volume30
Issue number7
DOIs
Publication statusPublished - 2010 May 1

Fingerprint

Fc Receptors
Meta-Analysis
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Alleles
Genotype
Ethnic Groups
Population

Keywords

  • FCRL3
  • Meta-analysis
  • Polymorphisms
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Fc receptor-like 3 - 169 C/T polymorphism and RA susceptibility : A meta-analysis. / Lee, Young Ho; Woo, Jin Hyun; Choi, Sungjae; Ji, Jong Dae; Song, Gwan Gyu.

In: Rheumatology International, Vol. 30, No. 7, 01.05.2010, p. 947-953.

Research output: Contribution to journalArticle

@article{1256003d32174311a750a05b41409dc8,
title = "Fc receptor-like 3 - 169 C/T polymorphism and RA susceptibility: A meta-analysis",
abstract = "The Fc receptor-like 3 (FCRL3) -169 C/T polymorphism has been reported to be associated with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), but with inconsistent results. The aim of this study was to explore whether the FCRL3 -169 C/T polymorphism confers susceptibility to RA and SLE. The authors conducted a random effect meta-analysis on the associations between the C/C (recessive effect) or C/C + C/T (dominant effect) genotype or the allele C of the FCRL3 -169 polymorphisms and RA or SLE in different populations. In total, 15 separate comparisons, 12 for RA and 3 for SLE, drawn from nine European and six Asian population samples were included in this meta-analysis. No association between RA and the FCRL3 C allele was found for all study subjects (OR = 1.064, 95{\%} CI = 0.987-1.146, p = 0.107). However, stratification by ethnicity indicated that the FCRL3 C allele was significantly associated with RA in Asians (OR = 1.203, 95{\%} CI = 1.097-31.319, p < 0.001). Conversely, no association was detected for this allele and RA in Europeans (OR = 0.997, 95{\%} CI = 0.931- 1.068, p = 0.933). The ORs for the C/C + C/T and C/C genotypes in these ethnic groups showed the same trends as the FCRL3 C allele. An association between SLE and the FCRL3 -169 A allele was found in all study subjects (OR = 1.115, 95{\%} CI = 1.003-1.240, p = 0.043), but metaanalysis excluding studies with controls not in HWE did not show the association. This meta-analysis suggests that the FCRL3 -169 C/T polymorphism is a significant risk factor for RA in Asians, but not in Europeans.",
keywords = "FCRL3, Meta-analysis, Polymorphisms, Rheumatoid arthritis",
author = "Lee, {Young Ho} and Woo, {Jin Hyun} and Sungjae Choi and Ji, {Jong Dae} and Song, {Gwan Gyu}",
year = "2010",
month = "5",
day = "1",
doi = "10.1007/s00296-009-1082-5",
language = "English",
volume = "30",
pages = "947--953",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - Fc receptor-like 3 - 169 C/T polymorphism and RA susceptibility

T2 - A meta-analysis

AU - Lee, Young Ho

AU - Woo, Jin Hyun

AU - Choi, Sungjae

AU - Ji, Jong Dae

AU - Song, Gwan Gyu

PY - 2010/5/1

Y1 - 2010/5/1

N2 - The Fc receptor-like 3 (FCRL3) -169 C/T polymorphism has been reported to be associated with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), but with inconsistent results. The aim of this study was to explore whether the FCRL3 -169 C/T polymorphism confers susceptibility to RA and SLE. The authors conducted a random effect meta-analysis on the associations between the C/C (recessive effect) or C/C + C/T (dominant effect) genotype or the allele C of the FCRL3 -169 polymorphisms and RA or SLE in different populations. In total, 15 separate comparisons, 12 for RA and 3 for SLE, drawn from nine European and six Asian population samples were included in this meta-analysis. No association between RA and the FCRL3 C allele was found for all study subjects (OR = 1.064, 95% CI = 0.987-1.146, p = 0.107). However, stratification by ethnicity indicated that the FCRL3 C allele was significantly associated with RA in Asians (OR = 1.203, 95% CI = 1.097-31.319, p < 0.001). Conversely, no association was detected for this allele and RA in Europeans (OR = 0.997, 95% CI = 0.931- 1.068, p = 0.933). The ORs for the C/C + C/T and C/C genotypes in these ethnic groups showed the same trends as the FCRL3 C allele. An association between SLE and the FCRL3 -169 A allele was found in all study subjects (OR = 1.115, 95% CI = 1.003-1.240, p = 0.043), but metaanalysis excluding studies with controls not in HWE did not show the association. This meta-analysis suggests that the FCRL3 -169 C/T polymorphism is a significant risk factor for RA in Asians, but not in Europeans.

AB - The Fc receptor-like 3 (FCRL3) -169 C/T polymorphism has been reported to be associated with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), but with inconsistent results. The aim of this study was to explore whether the FCRL3 -169 C/T polymorphism confers susceptibility to RA and SLE. The authors conducted a random effect meta-analysis on the associations between the C/C (recessive effect) or C/C + C/T (dominant effect) genotype or the allele C of the FCRL3 -169 polymorphisms and RA or SLE in different populations. In total, 15 separate comparisons, 12 for RA and 3 for SLE, drawn from nine European and six Asian population samples were included in this meta-analysis. No association between RA and the FCRL3 C allele was found for all study subjects (OR = 1.064, 95% CI = 0.987-1.146, p = 0.107). However, stratification by ethnicity indicated that the FCRL3 C allele was significantly associated with RA in Asians (OR = 1.203, 95% CI = 1.097-31.319, p < 0.001). Conversely, no association was detected for this allele and RA in Europeans (OR = 0.997, 95% CI = 0.931- 1.068, p = 0.933). The ORs for the C/C + C/T and C/C genotypes in these ethnic groups showed the same trends as the FCRL3 C allele. An association between SLE and the FCRL3 -169 A allele was found in all study subjects (OR = 1.115, 95% CI = 1.003-1.240, p = 0.043), but metaanalysis excluding studies with controls not in HWE did not show the association. This meta-analysis suggests that the FCRL3 -169 C/T polymorphism is a significant risk factor for RA in Asians, but not in Europeans.

KW - FCRL3

KW - Meta-analysis

KW - Polymorphisms

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=77955097204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955097204&partnerID=8YFLogxK

U2 - 10.1007/s00296-009-1082-5

DO - 10.1007/s00296-009-1082-5

M3 - Article

VL - 30

SP - 947

EP - 953

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 7

ER -